CCL19 anticorps (AA 22-98)
Aperçu rapide pour CCL19 anticorps (AA 22-98) (ABIN2618133)
Antigène
Voir toutes CCL19 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 22-98
-
Specificité
- Human CCL19 / MIP3-Beta
-
Purification
- Immunoaffinity purified
-
Immunogène
-
Human recombinant protein fragment corresponding to amino acids 22-98 of human CCL19 (NP_006265) produced in E. coli.
Type of Immunogen: Recombinant protein -
Isotype
- IgG1
-
-
-
-
Indications d'application
- Approved: IHC, IHC-P (1:150)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.3, 1 % BSA, 50 % glycerol, 0.02 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Minimize freezing and thawing.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze-thaw cycles.
-
-
- CCL19 (Chemokine (C-C Motif) Ligand 19 (CCL19))
-
Autre désignation
- CCL19 / MIP3-beta
-
Sujet
-
Name/Gene ID: CCL19
Subfamily: Intercrine beta
Family: Intercrine
Synonyms: CCL19, C-C motif chemokine 19, CKb11, CC chemokine ligand 19, EBI1 ligand chemokine, EBI1-ligand chemokine, Exodus-3, ELC, MIP-3-beta, MIP3B, SCYA19, Small-inducible cytokine A19, Beta chemokine exodus-3, Beta-chemokine exodus-3, CK beta-11, MIP-3b -
ID gène
- 6363
-
NCBI Accession
- NP_006265
-
Pathways
- Positive Regulation of Immune Effector Process
Antigène
-